SUMMARY A spectrophotometric assay of proteolytic enzyme activity is described in which the optical density obtained by a given enzyme preparation is related (2x < 0.01) to ANTISERA AND SEROLOGICAL TECHNIQUES Seven antisera were used: anti-D, anti-c(2), anti-e, anti-k, anti-Ce and anti-Wr(a). All antisera contained incomplete antibodies which failed to agglutinate cells suspended in saline. One ml doubling dilutions from 1/1 to 1/512 in saline were prepared of each antiserum and 17 identical sets of dilutions were prepared from these master dilutions. Each set was tested as described below with the appropriate red cells pretreated with a different enzyme preparation. One volume (30 Al) antiserum dilution was mixed and incubated with one volume of a 3% suspension of enzyme treated cells for one hour at 37°C. The cell buttons were transferred to a glass slide. The results were read macroscopically and microscopically and the strengths of reaction were scored on a scale from 0-7. All serological tests were performed on the same day for each antiserum. As a negative control, a normal human serum, free of any unexpected blood group antibodies, was incubated with each enzyme treated red cell preparation.
In contrast to most other reagents used in blood group serology, proteolytic enzyme solutions are frequently prepared by individual users. Procedures for the standardisation of these products are, however, not well established. A spectrophotometric technique for the assay of protease activity using azoalbumin has previously been reported. ' In our hands this assay lacked sensitivity. The assay was modified in order to improve the sensitivity and a study was then undertaken to reassess the value of the assay in the standardisation of proteolytic enzyme preparations for use in a two-stage serological technique.
Material and methods ENZYME PREPARATIONS Seventeen enzyme preparations were obtained from 11 different commercial suppliers: seven powder papain preparations, four powder bromelain preparations, two liquid papain preparations, one freeze-dried preparation of papain and three freeze-dried preparations of bromelain. From each powder preparation, 10 g/l solution was prepared in 0-067 M phosphate buffer, pH 5-4, with 0-5 M 1-cysteine, by the method of Low.2 Liquid preparations were used as provided. Freeze-dried preparations were reconstituted according to manufactur- ers' instructions. All One hundred microlitres of enzyme preparation were added to 1 ml of azoalbumin (Sigma) 20 mg/ml in 0-067 M Sorensen's phosphate buffer pH 5*4, mixed and incubated at 37°C for 30 min. One ml of 50 g/l trichloroacetic acid was added and the reaction mixture centrifuged at 1000 g for 5 min.
One ml of supernatant was added to 1 ml of 0-5 M 329 24-4 3 1.14 x 2* 2 *These two preparations were of such activity that an initial 1/2 dilution was required for assay to obtain these values.
NaOH. The optical density was determined at 440 nm against a reagent control obtained by incubating the azoalbumin preparation with phosphate buffer pH 5-4, in the absence of enzyme. Azoalbumin assays were performed together on the same day in duplicate.
Results
The azoalbumin method as employed for the assessment of proteolytic enzyme preparations used .5 *1S A modified azoalbumin technique for the assay ofproteolytic enzymes for use in blood group serology 331
The ranked optical densities and ranked mean titration scores of the seven antisera were significantly related (Spearman's rank correlation coefficient = 0-76, that is 0.001 < 2 x < 0-01).3 The relation is shown graphically in the Figure. There was no significant relation between ranked optical densities and the ranked scores of the normal serum (coefficient = 0-19, 2xc > 0-10). There was no relation between the ranked scores for the normal serum and the ranked mean scores with the seven antisera.
Discussion
Proteolytic enzymes, in particular papain and bromelain, are widely used for the detection of antibodies to red cell antigens. Recent surveys undertaken as part of the UK National External Quality Assessment Scheme (NEQAS) in blood group serology indicate that the use of enzymes in compatibility testing is increasing although the enzyme crossmatch technique is the least reliable for the detection of incomplete blood group antibodies.5
The NEQAS surveys revealed that enzyme preparations are obtained from many different sources and that working enzyme solutions may be prepared within the users' laboratories (25%), by Regional Transfusion Centres (36%) or by commercial suppliers (39%).5 While some commercial suppliers provide working enzyme preparations ready-for-use as liquid "stabilised" enzyme preparations or as freeze-dried material for reconstitution, the majority of working enzyme solutions are prepared from crude powder extracts in hospitals or Regional Transfusion Centres. However, few practical methods are available for standardisation of such preparations. Enzyme solutions are usually assessed serologically but, in the absence of suitable reference preparations, this approach is unlikely to be reliable.
The results obtained using the azoalbumin technique were very similar to those obtained serologically. In that respect little was gained but the azoalbumin technique has considerable advantages in precision and ease of performance. It was not clear from the spread of the mean agglutination scores obtained by the seventeen enzyme preparations if any of the preparations gave optimal agglutination reactions. A limiting factor for the potency of enzyme preparations is their propensity to give rise to "false positive" results-that is, agglutination of cells in the presence of normal serum which is free of any antibody. In the present study there was no evidence that the most potent preparations gave higher agglutination scores with the normal serum than the weaker enzyme preparations.
In its present state of development the azoalbumin assay can only determine the relative potencies of enzyme preparations. This may be of value to manufacturers of enzyme preparations in selection of raw material, but is of limited value in the assessment of individual preparations at the user level. It would clearly be useful to develop the azoalbumin assay to obtain quantitative expressions of enzyme potency, to determine the optimal range of enzyme concentration and to develop stable reference preparations which could define minimum requirements for producers and users alike.
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